Paper41892432
Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions.
Miftode IL and 9 others. Antibiotics (Basel), 2026. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions. Papers, record 41892432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41892432
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References179
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41,009,897 | Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41009897 | PubMed |
| 2 | 40,503,958 | Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas-derived cephalosporinase variant PDC-88. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40503958 | PubMed |
| 3 | 39,144,447 | Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation. | JAC Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39144447 | PubMed |
| 4 | 37,566,365 | Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland. | Eur J Clin Microbiol Infect Dis | 2023 | https://conductscience.org/library/papers/37566365 | PubMed |
| 5 | 39,978,636 | Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia: a 5-year cohort study in intensive care patients. | Clin Microbiol Infect | 2025 | https://conductscience.org/library/papers/39978636 | PubMed |
| 6 | 39,162,506 | RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/39162506 | PubMed |
| 7 | 40,555,322 | Metagenomic and whole-genome characterization of carbapenem-resistant Acinetobacter baumannii carrying blaOXA-23 gene within the Tn2006 transposon among ICU patients. | J Glob Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40555322 | PubMed |
| 8 | 38,402,870 | Whole Genome Sequencing: Applications in Clinical Bacteriology. | Med Princ Pract | 2024 | https://conductscience.org/library/papers/38402870 | PubMed |
| 9 | 37,901,589 | Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae. | JAC Antimicrob Resist | 2023 | https://conductscience.org/library/papers/37901589 | PubMed |
| 10 | 38,078,718 | False-positive imipenemase detected by NG-Test CARBA-5 in carbapenem-resistant Acinetobacter baumannii. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38078718 | PubMed |
| 11 | 33,069,233 | Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae. | BMC Microbiol | 2020 | https://conductscience.org/library/papers/33069233 | PubMed |
| 12 | 38,406,830 | Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/38406830 | PubMed |
| 13 | 37,125,466 | Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37125466 | PubMed |
| 14 | 39,672,348 | In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China. | Int J Antimicrob Agents | 2025 | https://conductscience.org/library/papers/39672348 | PubMed |
| 15 | 37,623,430 | Molecular characterization and comparison of bla NDM-1-carrying and bla NDM-5-harboring IncX3-type plasmids in carbapenem-resistant Klebsiella pneumoniae. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37623430 | PubMed |
| 16 | 38,506,533 | Outbreak of NDM-5-producing Klebsiella pneumoniae ST307: an emerging high-risk antimicrobial resistance clone in Shanghai, China. | mSystems | 2024 | https://conductscience.org/library/papers/38506533 | PubMed |
| 17 | 39,210,044 | Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39210044 | PubMed |
| 18 | 40,240,992 | Loss of OprD function is sufficient for carbapenem-resistance-only but insufficient for multidrug resistance in Pseudomonas aeruginosa. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40240992 | PubMed |
| 19 | 37,325,251 | Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization. | JAC Antimicrob Resist | 2023 | https://conductscience.org/library/papers/37325251 | PubMed |
| 20 | 40,310,344 | Assessment of Phenotypic Tools for Detection of OXA-48, KPC, and NDM in Klebsiella pneumoniae in Oman. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40310344 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,989,078 | Clinical infection and molecular characteristics of carbapenem-resistant organisms among children in China, 2016-2025. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42989078 | PubMed |
| 42,938,701 | Whole-Genome Analysis of Genomic Diversity and Antimicrobial Resistance Among Clinical Klebsiella pneumoniae Isolates from Farwaniya Hospital in Kuwait. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42938701 | PubMed |
| 42,798,984 | Glutamate Potentiates Meropenem Killing of Carbapenem-Resistant Pseudomonas aeruginosa by Increasing Outer Membrane Permeability to Increase Uptake. | ACS Omega | 2026 | https://conductscience.org/library/papers/42798984 | PubMed |
| 42,792,035 | Rising Carbapenem MICs and Clinical Dose Optimization: Bridging Resistance Surveillance and Pharmacokinetic/Pharmacodynamic Strategies. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42792035 | PubMed |
| 42,357,333 | Pre-Target Interception Defines Carbapenem Failure in Carbapenem-Resistant Enterobacterales: A Mechanistic Framework for Spatiotemporal Drug Reprogramming. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357333 | PubMed |
| 42,353,110 | Phylogenetic Relationships and Structural Conservation of blaOXA-48-like Carbapenemase in Multispecies Clinical Strains from an Intensive Care Unit in Pakistan. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353110 | PubMed |
| 42,248,958 | Whole-genome sequencing reveals high-risk ESBL and carbapenemase-producing Enterobacterales on maternity ward surfaces in Cameroon. | Sci Rep | 2026 | https://conductscience.org/library/papers/42248958 | PubMed |
| 42,240,081 | Duplex Recombinase Polymerase Amplification-Lateral Flow Assay for Rapid Visual Detection of Critical Antibiotic Resistance Genes in Escherichia coli and Klebsiella pneumoniae From Positive Blood Cultures. | J Clin Lab Anal | 2026 | https://conductscience.org/library/papers/42240081 | PubMed |
| 42,197,440 | KPC-2 Orchestrates Systemic Metabolic Rewiring to Facilitate Antibiotic Adaptation in Klebsiella pneumoniae. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197440 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SNRPE | 6,635 | PubTator's text mining | https://conductscience.org/library/genes/6635 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41892432
GET https://conductscience.org/api/papers/v1/41892432/references?page=2